These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39237126)

  • 1. Enhanced prediction of atrial fibrillation risk using proteomic markers: a comparative analysis with clinical and polygenic risk scores.
    Liu M; Zhang Y; Ye Z; He P; Zhou C; Yang S; Zhang Y; Gan X; Qin X
    Heart; 2024 Oct; 110(21):1270-1276. PubMed ID: 39237126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
    Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
    Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
    Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
    Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
    Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
    Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Proteomic Insights for Identification of Novel Predictors and Potential Drug Targets in Atrial Fibrillation: A Prospective Cohort Study and Mendelian Randomization Analysis.
    Peng X; Li Y; Liu N; Xia S; Li X; Lai Y; He L; Sang C; Dong J; Ma C
    Circ Arrhythm Electrophysiol; 2024 Oct; 17(10):e013037. PubMed ID: 39355913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
    Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
    Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
    Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
    J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
    Jonmundsson T; Steindorsdottir AE; Austin TR; Frick EA; Axelsson GT; Launer L; Psaty BM; Loureiro J; Orth AP; Aspelund T; Emilsson V; Floyd JS; Jennings L; Gudnason V; Gudmundsdottir V
    Europace; 2023 Nov; 25(11):. PubMed ID: 37967346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
    Börschel CS; Ohlrogge AH; Geelhoed B; Niiranen T; Havulinna AS; Palosaari T; Jousilahti P; Rienstra M; van der Harst P; Blankenberg S; Zeller T; Salomaa V; Schnabel RB
    Europace; 2021 May; 23(5):674-681. PubMed ID: 33458771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
    Marston NA; Garfinkel AC; Kamanu FK; Melloni GM; Roselli C; Jarolim P; Berg DD; Bhatt DL; Bonaca MP; Cannon CP; Giugliano RP; O'Donoghue ML; Raz I; Scirica BM; Braunwald E; Morrow DA; Ellinor PT; Lubitz SA; Sabatine MS; Ruff CT
    Eur Heart J; 2023 Jan; 44(3):221-231. PubMed ID: 35980763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.
    Patton KK; Heckbert SR; Alonso A; Bahrami H; Lima JA; Burke G; Kronmal RA
    Heart; 2013 Dec; 99(24):1832-6. PubMed ID: 24131775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
    Costa MD; Redline S; Soliman EZ; Goldberger AL; Heckbert SR
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H256-H271. PubMed ID: 32986961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CAC
    Naghavi M; Yankelevitz D; Reeves AP; Budoff MJ; Li D; Atlas K; Zhang C; Atlas TL; Lirette S; Wasserthal J; Roy SK; Henschke C; Wong ND; Defilippi C; Heckbert SR; Greenland P
    J Cardiovasc Comput Tomogr; 2024; 18(4):383-391. PubMed ID: 38653606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
    Haller PM; Jarolim P; Palazzolo MG; Bellavia A; Antman EM; Eikelboom J; Granger CB; Harrington J; Healey JS; Hijazi Z; Patel MR; Patel SM; Ruff CT; Wallentin L; Braunwald E; Giugliano RP; Morrow DA
    J Am Coll Cardiol; 2024 Oct; 84(16):1528-1540. PubMed ID: 39230543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.